11.31% More Vbi Vaccines Inc – Ordinary Shares (NASDAQ:VBIV) Short Interest

June 27, 2018 - By Alex Paulin

VBI Vaccines Inc. (NASDAQ:VBIV) Corporate Logo

It was noted an increase on Vbi Vaccines Inc – Ordinary Shares (NASDAQ:VBIV)’s short interest with 11.31%. FINRA announced short interest of VBIV’s total 820,900 shares. That’s 11.31% up from 737,500 shares. 6 days will cost VBIV with 131,400 average volume to restore its former position. Vbi Vaccines Inc – Ordinary Shares’s short interest float is 2.14%.

VBIV hit $2.85 during the last trading session after $0.08 change.Currently VBI Vaccines Inc. is downtrending after 26.86% change in last June 27, 2017. VBIV has also 105,434 shares volume. The stock underperformed the S&P500 by 39.43%.

VBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally.The firm is valued at $183.02 million. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process.Currently it has negative earnings. The firm also offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborn infants.

There’s a substantial VBI Vaccines Inc. (NASDAQ:VBIV) news released by Globenewswire.com. It’s an item titled: “VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference” on June 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: